BDR Pharmaceutical, a major pharmaceutical business, has announced the introduction of Zisavel capsules, the first-of-its-kind generic medicine for the treatment of invasive aspergillosis and mucormycosis. Zisavel belongs to the isavuconazole...
The FDA has approved Ryzumvi (phentolamine ophthalmic solution) 0.75% for the treatment of pharmacologically-induced mydriasis caused by adrenergic agonists (e.g., phenylephrine) or parasympatholytic (e.g., tropicamide). Ryzumvl is projected to...
Biosimilars, akin to their originator biologics, offer a promising avenue for addressing the complex needs of individuals battling chronic illnesses
Global pharma major Lupin Limited (Lupin) announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (FDA) for its Nagpur Unit-1 manufacturing facility that...
Everest Medicines, a biopharmaceutical company focused on the development, manufacturing, and commercialization of novel medicines and vaccines, announced that the Taiwan Food and Drug Administration (TFDA) has approved the New Drug Applica...
Sun Pharmaceutical Industries Ltd announced an MXN 161.85 million (about Rs 75 crore) acquisition of local partner Indi Pharma from its Mexican branch. Sun Pharmaceutical Industries stated in a regulatory filing that it has signed a binding letter...
The market for mycobacterium tuberculosis tests in India is expected to grow at a compound annual growth rate of 4% between 2023 and 2033 as the country works to combat tuberculosis, a persistent global health challenge that continues to...
The US Food and Drug Administration (FDA) has authorized MRI conditional labeling for the Evoke System, the first and only precision, dose-control spinal cord stimulation (SCS) therapy driven by SmartLoop technology according to...
AffaMed Therapeutics, a global biotechnology company, announced that China's National Medical Products Administration has approved AffaMed’s Clinical Trial Application (CTA) to investigate the efficacy and safety of risuteganib (Luminate), its...
Kyverna Therapeutics, a clinical-stage cell therapy company focused on engineering a new class of therapies for serious autoimmune diseases, and ElevateBio, LLC, a technology-driven company focused on powering transformative cell and gene...
, CDSCO.jpg)
